AJP - Endocrinology and Metabolism, Vol 263, Issue 3 E435-E440, Copyright © 1992 by American Physiological Society

ARTICLES

Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics

G. Paolisso, G. Di Maro, G. Pizza, A. D'Amore, S. Sgambato, P. Tesauro, M. Varricchio and F. D'Onofrio
Department of Geriatric Medicine and Metabolic Diseases, 1st Medical School, University of Naples, Italy.

In healthy subjects (n = 10) and non-insulin-dependent (type II) diabetics (n = 10) matched for age [43.1 +/- 2.2 vs. 41 +/- 4.4 yr, P = not significant (NS)], body mass index (25.1 +/- 1.1 vs. 26 +/- 0.8 kg/m2, P = NS), gender ratio [5 males (M)/5 females (F) vs. 5M/5F], and mean arterial blood pressure (105 +/- 7 vs. 106 +/- 9 mmHg, P = NS), we determined the changes in insulin secretion and action after glutathione infusion (15 mg/min) and the relative increase in the plasma reduced (GSH)/oxidized (GSSG) glutathione ratio. The rise in the plasma GSH/GSSG ratio significantly improved total body glucose disposal in healthy subjects and in diabetic patients. In this latter group, GSH infusion potentiated the beta-cell response to glucose slightly. In controls and diabetics, insulin infusion with a simultaneous increase in the plasma GSH/GSSG ratio significantly enhanced nonoxidative glucose disposal without affecting oxidative glucose metabolism. After glutathione infusion, all metabolic and hormonal changes correlated with a significant decline in plasma membrane microviscosity. In conclusion, the plasma GSH/GSSG ratio seems to play a major role in the modulation of glucose homeostasis mainly in diabetics.

This article has been cited by other articles:

				T. Nystrom, A. Nygren, and A. Sjoholm Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E919 - E925. [Abstract] [Full Text] [PDF]

				C. A. Haber, T. K. T. Lam, Z. Yu, N. Gupta, T. Goh, E. Bogdanovic, A. Giacca, and I. G. Fantus N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E744 - E753. [Abstract] [Full Text] [PDF]

				M. P. Guarino, R. A. Afonso, N. Raimundo, J. F. Raposo, and M. P. Macedo Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G588 - G594. [Abstract] [Full Text] [PDF]

				J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Are Oxidative Stress-Activated Signaling Pathways Mediators of Insulin Resistance and {beta}-Cell Dysfunction? Diabetes, January 1, 2003; 52(1): 1 - 8. [Abstract] [Full Text] [PDF]

				M. Barbagallo, L. J. Dominguez, M. R. Tagliamonte, L. M. Resnick, and G. Paolisso Effects of Vitamin E and Glutathione on Glucose Metabolism : Role of Magnesium Hypertension, October 1, 1999; 34(4): 1002 - 1006. [Abstract] [Full Text] [PDF]

				M. Barbagallo, L. J. Dominguez, M. R. Tagliamonte, L. M. Resnick, and G. Paolisso Effects of Glutathione on Red Blood Cell Intracellular Magnesium : Relation to Glucose Metabolism Hypertension, July 1, 1999; 34(1): 76 - 82. [Abstract] [Full Text] [PDF]

				D. Giugliano, R. Marfella, L. Coppola, G. Verrazzo, R. Acampora, R. Giunta, F. Nappo, C. Lucarelli, and F. D'Onofrio Vascular Effects of Acute Hyperglycemia in Humans Are Reversed by L-Arginine : Evidence for Reduced Availability of Nitric Oxide During Hyperglycemia Circulation, April 1, 1997; 95(7): 1783 - 1790. [Abstract] [Full Text]